10/05/2011
https://www.congress.gov...
"It's a risky decision. It's a decision that I don't support and hope that at the end of this process our committee will not look at what the administration has asked for, but look at what we would hop..."
"After last year's significant increase in the National Institutes of Health, it's time to again make research funding a national priority."
"If a drug is overpriced, it is not accessible to a consumer."
"If you cannot find one egregious example where you can apply this, I would be surprised."